Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01649453
NCT01649453TerminatedNot Applicable

A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test

Cedar Associates LLC1 site in 1 country19 target enrollmentStarted: May 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
19
Locations
1
Primary Endpoint
Survival
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013
  • •the patient is ≥ 18 years of age
  • •the patient has given informed consent (online or verbal)
  • •the patient is able to understand English.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Survival

Time Frame: 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Cedar Associates LLC
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

John Hornberger, MD MS

CEO, President

Cedar Associates LLC

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Treatment Outcomes of Retroperitoneal SarcomaRetroperitoneal Sarcoma
NCT06612671Taichung Veterans General Hospital150
Recruiting
Not Applicable
Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related TherapiesHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
NCT05108519M.D. Anderson Cancer Center170
Unknown
Not Applicable
Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) ScansCancerVenous Thromboembolism
NCT00925808M.D. Anderson Cancer Center1,187
Recruiting
Not Applicable
Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast CancerBreast Cancer
NCT05933733Samsung Medical Center190
Terminated
Not Applicable
Patient Reported Outcome Measures (PROMs) With TrabectedinSarcomaLeiomyosarcomaLiposarcoma
NCT03959033University of Leeds7